Ghodsiyeh Azarkar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ghodsiyeh Azarkar has a total of 46 co-authors. Here are the top co-authors by number of shared publications:
- Masood Ziaee
Infectious Diseases Research Center, Birjand University of Medical Sciences, Birjand, Iran
10 shared publications - Gholamreza Sharifzadeh
Department of Epidemiology and Biostatistics, School of Health, Social Determinants of Health Research Center, Birjand University of Medical Sciences, Birjand, Iran
4 shared publications Arash Ziaee
Department of Radiology, Faculty of Medicine, Birjand University of Medical Sciences, Birjand, Iran
3 shared publications- Arash Ziaee
Birjand University of Medical Sciences, Iran
3 shared publications Arghavan Asghari
Infectious Diseases Research Center, Birjand University of Medical Sciences, Birjand, Iran
2 shared publicationsBita Bijari
Infectious Disease Research Center, Birjand University of Medical Sciences, Birjand, Iran,
2 shared publications
Latest Publications
- 1 February 2026
- Published by InkVista Publishing House
- Vol. 32 (4) , 316-325
Prevalence of diffuse idiopathic skeletal hyperostosis based on chest computed tomography scans, 2019-2020
- 1 February 2026
- Published by InkVista Publishing House
- Vol. 32 (4) , 316-325
Prevalence of diffuse idiopathic skeletal hyperostosis based on chest computed tomography scans, 2019-2020
- 3 September 2025
- Published by Georg Thieme Verlag KG in International Journal of Angiology
Prevalence of Abdominal Aortic Aneurysm in Patients with Coronary Artery Stenosis Undergoing Angiography from 2011 to 2016
An abdominal aortic aneurysm (AAA) is an abnormal local dilation of the aorta. The relationship between coronary artery disease (CAD) and the AAA is well established. This study evaluated the prevalence of AAAs in patients with CAD who underwent angiography in a hospital. Between 2011 and 2016, a total of 576 patients with coronary artery stenosis and a stenosis level greater than 50% in at least one of their coronary arteries were referred for angiography. Patient data were collected from medical records, and a checklist was created to document demographic information, underlying medical conditions, and ultrasound findings. Data were analyzed using either the chi-square or Fisher's exact test, depending on the specific variables being examined. The prevalence of AAAs among 576 patients with CAD was 6.3%. The difference in the distribution of AAAs in patients based on smoking (p = 0.003) and high blood pressure history (p < 0.001) was statistically significant. AAAs in patients with CAD showed no significant difference in hyperlipidemia (p = 0.13) and diabetes (p = 0.06). The prevalence of AAA was not associated with an increase in the number of involved vessels (p = 0.06). The prevalence of AAAs in patients with CAD angiography was found to be 6.3%. The prevalence increased significantly with age, and females had a higher prevalence than males. The prevalence increased with the increased number of involved vessels but not significantly. The study highlights the importance of prevention and early detection to avoid rupture and high mortality rates.
- 3 September 2025
- Published by Georg Thieme Verlag KG in International Journal of Angiology
Prevalence of Abdominal Aortic Aneurysm in Patients with Coronary Artery Stenosis Undergoing Angiography from 2011 to 2016
An abdominal aortic aneurysm (AAA) is an abnormal local dilation of the aorta. The relationship between coronary artery disease (CAD) and the AAA is well established. This study evaluated the prevalence of AAAs in patients with CAD who underwent angiography in a hospital. Between 2011 and 2016, a total of 576 patients with coronary artery stenosis and a stenosis level greater than 50% in at least one of their coronary arteries were referred for angiography. Patient data were collected from medical records, and a checklist was created to document demographic information, underlying medical conditions, and ultrasound findings. Data were analyzed using either the chi-square or Fisher's exact test, depending on the specific variables being examined. The prevalence of AAAs among 576 patients with CAD was 6.3%. The difference in the distribution of AAAs in patients based on smoking (p = 0.003) and high blood pressure history (p < 0.001) was statistically significant. AAAs in patients with CAD showed no significant difference in hyperlipidemia (p = 0.13) and diabetes (p = 0.06). The prevalence of AAA was not associated with an increase in the number of involved vessels (p = 0.06). The prevalence of AAAs in patients with CAD angiography was found to be 6.3%. The prevalence increased significantly with age, and females had a higher prevalence than males. The prevalence increased with the increased number of involved vessels but not significantly. The study highlights the importance of prevention and early detection to avoid rupture and high mortality rates.
- Open Access
- 6 August 2025
- Published by Revista Mexicana de Urologia based at Sociedad Mexicana de Urologia. Colegio de Profesionales AC. in Revista Mexicana de Urología
- Vol. 85 (3) , 1-10
Association between non-alcoholic fatty liver disease and urolithiasis: a cross-sectional study
Background: urolithiasis, the formation of kidney stones, is associated with chronic conditions such as metabolic syndrome, which increases the risk of uric acid and calcium oxalate stones. Based on CT scan findings, this study aims to investigate the association between non-alcoholic fatty liver disease (NAFLD) and urolithiasis. Method: over two years, a cross-sectional comparative study was conducted at Razi Hospital in Birjand, Iran. Participants were patients aged 16 to 80 presenting with renal colic who underwent non-contrast abdominopelvic CT scans. Exclusion criteria included other liver diseases, excessive alcohol consumption, and a history of splenectomy. Data were collected using a structured checklist and analyzed for the presence of fatty liver and kidney stones. Results: the study included 911 participants, with a mean age of 47.88 years (SD = 16.48). Among the participants, 80 had fatty liver disease, and 50 of these had kidney stones. In contrast, of the 831 participants without fatty liver, 356 had kidney stones. The association between fatty liver and kidney stones was significant (p < 0.001). Gender-stratified analysis showed that males with fatty liver had a higher incidence of kidney stones compared to females (p < 0.001 for males, p = 0.631 for females). Conclusion: the study confirms a significant association between NAFLD and urolithiasis, particularly in males. The findings suggest that screening for kidney stones in patients with fatty liver disease might be beneficial. Addressing underlying metabolic disorders could help mitigate the risk of developing both conditions.
- 6 August 2025
- Published by Revista Mexicana de Urologia based at Sociedad Mexicana de Urologia. Colegio de Profesionales AC. in Revista Mexicana de Urología
- Vol. 85 (3) , 1-10
Open AccessAssociation between non-alcoholic fatty liver disease and urolithiasis: a cross-sectional study
Background: urolithiasis, the formation of kidney stones, is associated with chronic conditions such as metabolic syndrome, which increases the risk of uric acid and calcium oxalate stones. Based on CT scan findings, this study aims to investigate the association between non-alcoholic fatty liver disease (NAFLD) and urolithiasis. Method: over two years, a cross-sectional comparative study was conducted at Razi Hospital in Birjand, Iran. Participants were patients aged 16 to 80 presenting with renal colic who underwent non-contrast abdominopelvic CT scans. Exclusion criteria included other liver diseases, excessive alcohol consumption, and a history of splenectomy. Data were collected using a structured checklist and analyzed for the presence of fatty liver and kidney stones. Results: the study included 911 participants, with a mean age of 47.88 years (SD = 16.48). Among the participants, 80 had fatty liver disease, and 50 of these had kidney stones. In contrast, of the 831 participants without fatty liver, 356 had kidney stones. The association between fatty liver and kidney stones was significant (p < 0.001). Gender-stratified analysis showed that males with fatty liver had a higher incidence of kidney stones compared to females (p < 0.001 for males, p = 0.631 for females). Conclusion: the study confirms a significant association between NAFLD and urolithiasis, particularly in males. The findings suggest that screening for kidney stones in patients with fatty liver disease might be beneficial. Addressing underlying metabolic disorders could help mitigate the risk of developing both conditions.
- Open Access
- 1 April 2025
- Published by Brieflands in Modern Care Journal
- Vol. 22 (2)
Calcifying Pseudoneoplasm of the Neuraxis with Vasogenic Edema and Post-surgical Regrowth: A Case Report
Introduction: Calcifying pseudoneoplasm of the neuraxis (CAPNON) is a rare, benign central nervous system (CNS) lesion, first described in 1978. With approximately 150 reported cases, it remains poorly understood due to its rarity, variable presentation, and nonspecific features, often leading to misdiagnosis. Calcifying pseudoneoplasm of the neuraxis can occur anywhere along the neuraxis, with a slight predilection for intracranial sites. Surgical resection is the primary treatment, typically curative with low recurrence rates. This case report presents a unique instance of CAPNON, contributing to the understanding of its clinical spectrum and management challenges. Case Presentation: A 54-year-old female presented with urinary incontinence, bilateral arm weakness, and depressed mood. She had a medical history of a hysterectomy and a vertebral fracture. Initial magnetic resonance imaging (MRI) revealed a 35 × 27 × 33 mm left frontal lobe mass with mixed solid and cystic components, central calcification, heterogeneous enhancement of the solid portion, and surrounding vasogenic edema — an atypical finding for CAPNON. Surgical resection confirmed CAPNON histopathologically, showing a chondromyxoid matrix with calcifications and inflammatory infiltrate. Post-surgery, the patient’s symptoms improved, but follow-up MRIs at 8 and 12 months showed residual tumor growth from 18 × 15 × 13 mm to 21 × 24 × 26 mm. Consequently, the patient underwent intensity-modulated radiation therapy (IMRT) with 54 Gy in 27 fractions. Conclusions: This case of CAPNON is notable for its atypical presentation with vasogenic edema, post-surgical tumor regrowth, and the subsequent use of radiotherapy — features that challenge the conventional perception of CAPNON as uniformly benign and surgically curable. It underscores the potential for unexpected behaviors in CAPNON and the necessity for tailored management strategies beyond standard surgical resection.
- 1 April 2025
- Published by Brieflands in Modern Care Journal
- Vol. 22 (2)
Open AccessCalcifying Pseudoneoplasm of the Neuraxis with Vasogenic Edema and Post-surgical Regrowth: A Case Report
Introduction: Calcifying pseudoneoplasm of the neuraxis (CAPNON) is a rare, benign central nervous system (CNS) lesion, first described in 1978. With approximately 150 reported cases, it remains poorly understood due to its rarity, variable presentation, and nonspecific features, often leading to misdiagnosis. Calcifying pseudoneoplasm of the neuraxis can occur anywhere along the neuraxis, with a slight predilection for intracranial sites. Surgical resection is the primary treatment, typically curative with low recurrence rates. This case report presents a unique instance of CAPNON, contributing to the understanding of its clinical spectrum and management challenges. Case Presentation: A 54-year-old female presented with urinary incontinence, bilateral arm weakness, and depressed mood. She had a medical history of a hysterectomy and a vertebral fracture. Initial magnetic resonance imaging (MRI) revealed a 35 × 27 × 33 mm left frontal lobe mass with mixed solid and cystic components, central calcification, heterogeneous enhancement of the solid portion, and surrounding vasogenic edema — an atypical finding for CAPNON. Surgical resection confirmed CAPNON histopathologically, showing a chondromyxoid matrix with calcifications and inflammatory infiltrate. Post-surgery, the patient’s symptoms improved, but follow-up MRIs at 8 and 12 months showed residual tumor growth from 18 × 15 × 13 mm to 21 × 24 × 26 mm. Consequently, the patient underwent intensity-modulated radiation therapy (IMRT) with 54 Gy in 27 fractions. Conclusions: This case of CAPNON is notable for its atypical presentation with vasogenic edema, post-surgical tumor regrowth, and the subsequent use of radiotherapy — features that challenge the conventional perception of CAPNON as uniformly benign and surgically curable. It underscores the potential for unexpected behaviors in CAPNON and the necessity for tailored management strategies beyond standard surgical resection.
- Open Access
- 1 January 2024
- Published by SAGE Publications in Journal of Medical Education and Curricular Development
- Vol. 11
Unpacking HPV Stigma: Assessing Healthcare Workers’ Knowledge and Stigma Towards HPV While Exploring the Connection Between the Two
Objectives: Human Papillomavirus (HPV) is a leading cause of cervical cancer, yet existing social stigmas and unequal access to healthcare compromise its preventability through screening and vaccination. Understanding healthcare professionals’ knowledge and perceptions of HPV is pivotal in enhancing the quality and effectiveness of preventive healthcare strategies. This article aims to explore and understand the relationship between healthcare workers’ knowledge and stigma towards HPV. Design and Methods: A questionnaire of 27 stigma and 24 knowledge questions was provided for healthcare personnel. Demographic questions were also included. Stigma levels were determined based on a total median score. Fully adjusted multinomial logistic regression models were used to find the correlation between knowledge regarding HPV and the stigma level. Results: Five hundred fifty-two healthcare workers answered the questionnaire. The findings showed that while most participants had adequate to moderate knowledge about the prevention and complications of HPV, they lacked knowledge about symptoms and treatment. Stigma towards HPV disease was evident in some participants, with attitudes varying depending on demographic factors and knowledge level. The model indicated that age, gender, and specific knowledge questions were significantly associated with stigma levels. Interestingly, the presence of knowledge in some areas increased the stigma level. Conclusions: In conclusion, the study sheds light on the stigmatization and knowledge gaps regarding HPV disease among healthcare personnel and, intriguingly, that increased knowledge does not necessarily correlate with decreased stigma. The findings highlight the need for targeted education and training programs to improve healthcare providers’ knowledge in these specific areas.
- 1 January 2024
- Published by SAGE Publications in Journal of Medical Education and Curricular Development
- Vol. 11
Open AccessUnpacking HPV Stigma: Assessing Healthcare Workers’ Knowledge and Stigma Towards HPV While Exploring the Connection Between the Two
Objectives: Human Papillomavirus (HPV) is a leading cause of cervical cancer, yet existing social stigmas and unequal access to healthcare compromise its preventability through screening and vaccination. Understanding healthcare professionals’ knowledge and perceptions of HPV is pivotal in enhancing the quality and effectiveness of preventive healthcare strategies. This article aims to explore and understand the relationship between healthcare workers’ knowledge and stigma towards HPV. Design and Methods: A questionnaire of 27 stigma and 24 knowledge questions was provided for healthcare personnel. Demographic questions were also included. Stigma levels were determined based on a total median score. Fully adjusted multinomial logistic regression models were used to find the correlation between knowledge regarding HPV and the stigma level. Results: Five hundred fifty-two healthcare workers answered the questionnaire. The findings showed that while most participants had adequate to moderate knowledge about the prevention and complications of HPV, they lacked knowledge about symptoms and treatment. Stigma towards HPV disease was evident in some participants, with attitudes varying depending on demographic factors and knowledge level. The model indicated that age, gender, and specific knowledge questions were significantly associated with stigma levels. Interestingly, the presence of knowledge in some areas increased the stigma level. Conclusions: In conclusion, the study sheds light on the stigmatization and knowledge gaps regarding HPV disease among healthcare personnel and, intriguingly, that increased knowledge does not necessarily correlate with decreased stigma. The findings highlight the need for targeted education and training programs to improve healthcare providers’ knowledge in these specific areas.
- Open Access
- 3 October 2023
- Published by Ubiquity Press, Ltd. in Journal of the Belgian Society of Radiology
- Vol. 107 (1) , 80
Assessing the Prevalence of Ectopic Cerebellar Tonsils and Accompanying Symptoms in Individuals with Various Headaches
Chiari malformation exhibits well-defined clinical signs, symptoms, and incidence rates in clinical studies. However, cerebellar tonsil ectopia presents with ambiguous symptoms and undetermined incidence rates in numerous studies. Our objective was to determine the incidence of cerebellar tonsil ectopia in individuals with headaches and identify additional clinical symptoms. This aims to improve diagnosis accuracy for clinicians and neurologists, leading to more effective treatment approaches. A cross-sectional study conducted in 2022 included 2305 participants aged 4–78 years presenting with headache. Chiari malformation was diagnosed using magnetic resonance imaging (MRI) scans, with a definition of cerebellar tonsil herniation extending beyond 5mm into the cervical canal. The prevalence of Chiari malformation was 3.4%, with no significant gender difference (p = 0.72). There was a significant correlation between Chiari malformation and headache exacerbation due to the Valsalva maneuver (p < 0.001) and the presence of vertigo (p < 0.001). No significant association was found between Chiari malformation and accompanying symptoms such as nausea (p = 0.43), photophobia (p = 0.2), phonophobia (p = 0.52), and speech disorders (p = 0.45). These findings suggest a notable prevalence of Chiari malformation among headache patients and its association with specific headache characteristics, such as acute and occipital headaches, exacerbation by the Valsalva maneuver, and the co-occurrence of vertigo. These results underscore the need to consider Chiari malformation in the differential diagnosis of patients presenting with these specific headache features.
- 3 October 2023
- Published by Ubiquity Press, Ltd. in Journal of the Belgian Society of Radiology
- Vol. 107 (1) , 80
Open AccessAssessing the Prevalence of Ectopic Cerebellar Tonsils and Accompanying Symptoms in Individuals with Various Headaches
Chiari malformation exhibits well-defined clinical signs, symptoms, and incidence rates in clinical studies. However, cerebellar tonsil ectopia presents with ambiguous symptoms and undetermined incidence rates in numerous studies. Our objective was to determine the incidence of cerebellar tonsil ectopia in individuals with headaches and identify additional clinical symptoms. This aims to improve diagnosis accuracy for clinicians and neurologists, leading to more effective treatment approaches. A cross-sectional study conducted in 2022 included 2305 participants aged 4–78 years presenting with headache. Chiari malformation was diagnosed using magnetic resonance imaging (MRI) scans, with a definition of cerebellar tonsil herniation extending beyond 5mm into the cervical canal. The prevalence of Chiari malformation was 3.4%, with no significant gender difference (p = 0.72). There was a significant correlation between Chiari malformation and headache exacerbation due to the Valsalva maneuver (p < 0.001) and the presence of vertigo (p < 0.001). No significant association was found between Chiari malformation and accompanying symptoms such as nausea (p = 0.43), photophobia (p = 0.2), phonophobia (p = 0.52), and speech disorders (p = 0.45). These findings suggest a notable prevalence of Chiari malformation among headache patients and its association with specific headache characteristics, such as acute and occipital headaches, exacerbation by the Valsalva maneuver, and the co-occurrence of vertigo. These results underscore the need to consider Chiari malformation in the differential diagnosis of patients presenting with these specific headache features.
- 1 June 2022
- Published by SAGE Publications in DNA and Cell Biology
- Vol. 41 (6) , 544-563
Potential of MicroRNAs As Biomarkers and Therapeutic Targets in Respiratory Viruses: A Literature Review
MicroRNAs (miRNAs) are small noncoding RNAs that regulate gene expression through recognition of cognate sequences and interference of transcriptional, translational, or epigenetic processes. Hundreds of miRNA genes have been found in diverse viruses, and many of these are phylogenetically conserved. Respiratory viruses are the most frequent causative agents of disease in humans, with a significant impact on morbidity and mortality worldwide. Recently, the role of miRNAs in respiratory viral gene regulation, as well as host gene regulation during disease progression, has become a field of interest. This review highlighted the importance of various miRNAs and their potential role in fighting with respiratory viruses as therapeutic molecules with a focus on COVID-19.
- 1 June 2022
- Published by SAGE Publications in DNA and Cell Biology
- Vol. 41 (6) , 544-563
Potential of MicroRNAs As Biomarkers and Therapeutic Targets in Respiratory Viruses: A Literature Review
MicroRNAs (miRNAs) are small noncoding RNAs that regulate gene expression through recognition of cognate sequences and interference of transcriptional, translational, or epigenetic processes. Hundreds of miRNA genes have been found in diverse viruses, and many of these are phylogenetically conserved. Respiratory viruses are the most frequent causative agents of disease in humans, with a significant impact on morbidity and mortality worldwide. Recently, the role of miRNAs in respiratory viral gene regulation, as well as host gene regulation during disease progression, has become a field of interest. This review highlighted the importance of various miRNAs and their potential role in fighting with respiratory viruses as therapeutic molecules with a focus on COVID-19.
- Open Access
- 26 September 2021
- Published by Springer Nature in European Journal of Medical Research
- Vol. 26 (1) , 1-8
Role of fatty liver in coronavirus disease 2019 patients’ disease severity and hospitalization length: a case–control study
Background and purpose: Fatty liver is one of the most common pre-existing illnesses; it can cause liver injury, leading to further complications in coronavirus disease 2019 patients. Our goal is to determine if pre-existing fatty liver is more prevalent in hospitalized COVID-19 patients compared to patients admitted before the SARS-CoV-2 pandemic and determine the disease severity among fatty liver patients.Experimental approach: This retrospective study involves a case and a control group consisting of 1162 patients; the case group contains hospitalized COVID-19 patients with positive PCR tests and available chest CT-scan; the control group contains patients with available chest CT-scan previous to the COVID-19 pandemic. Patients’ data such as liver Hounsfield unit, hospitalization length, number of affected lobes, and total lungs involvement score were extracted and compared between the patients.Results: The findings indicate that 37.9% of hospitalized COVID-19 patients have a pre-existing fatty liver, which is significantly higher (P < 0.001) than the prevalence of pre-existing fatty liver in control group patients (9.02%). In comparison to hospitalized non-fatty liver COVID-19 patients, data from hospitalized COVID-19 patients with fatty liver indicate a longer hospitalization length (6.81 ± 4.76P = 0.02), a higher total lungs involvement score (8.73 ± 5.28P < 0.001), and an increased number of affected lobes (4.42 ± 1.2P < 0.001).Conclusion: The statistical analysis shows fatty liver is significantly more prevalent among COVID-19 against non-COVID-19 patients, and they develop more severe disease and tend to be hospitalized for more extended periods.
- 26 September 2021
- Published by Springer Nature in European Journal of Medical Research
- Vol. 26 (1) , 1-8
Open AccessRole of fatty liver in coronavirus disease 2019 patients’ disease severity and hospitalization length: a case–control study
Background and purpose: Fatty liver is one of the most common pre-existing illnesses; it can cause liver injury, leading to further complications in coronavirus disease 2019 patients. Our goal is to determine if pre-existing fatty liver is more prevalent in hospitalized COVID-19 patients compared to patients admitted before the SARS-CoV-2 pandemic and determine the disease severity among fatty liver patients.Experimental approach: This retrospective study involves a case and a control group consisting of 1162 patients; the case group contains hospitalized COVID-19 patients with positive PCR tests and available chest CT-scan; the control group contains patients with available chest CT-scan previous to the COVID-19 pandemic. Patients’ data such as liver Hounsfield unit, hospitalization length, number of affected lobes, and total lungs involvement score were extracted and compared between the patients.Results: The findings indicate that 37.9% of hospitalized COVID-19 patients have a pre-existing fatty liver, which is significantly higher (P < 0.001) than the prevalence of pre-existing fatty liver in control group patients (9.02%). In comparison to hospitalized non-fatty liver COVID-19 patients, data from hospitalized COVID-19 patients with fatty liver indicate a longer hospitalization length (6.81 ± 4.76P = 0.02), a higher total lungs involvement score (8.73 ± 5.28P < 0.001), and an increased number of affected lobes (4.42 ± 1.2P < 0.001).Conclusion: The statistical analysis shows fatty liver is significantly more prevalent among COVID-19 against non-COVID-19 patients, and they develop more severe disease and tend to be hospitalized for more extended periods.
- Open Access
- 6 August 2021
- Published by Springer Nature in Research Square
Role of Fatty Liver in Coronavirus Disease 2019 Patients' Disease Severity and Hospitalization Length: a Case-control Study
BACKGROUND AND PURPOSEFatty liver is one of the most common pre-existing illnesses; it can cause liver injury, leading to further complications for coronavirus disease 2019 patients. Our goal is to determine if pre-existing fatty liver is more prevalent in hospitalized COVID-19 patients compared to patients administrated before the SARS-CoV-2 pandemic and determine the severity of the disease among fatty liver patients.EXPERIMENTAL APPROACHThis retro-perspective study involves a case and a control group consisting of 1162 patients; the case group contains hospitalized COVID-19 patients with positive PCR tests and available CT-scan; the control group contains patients with available imaging data previous to the COVID-19 pandemic. Patients’ data such as liver Hounsfield unit, days of hospitalization, number of affected lobes, and total lungs involvement score were extracted and compared between the patients.RESULTSThe findings indicate that 37.9% of hospitalized COVID-19 patients have a pre-existing fatty liver, which is significantly higher (P < 0.001) than the prevalence of pre-existing fatty liver in control group patients (9.02%). In comparison to hospitalized non-fatty liver COVID-19 patients, data from hospitalized COVID-19 patients with fatty liver indicates longer hospitalization length (6.81 ± 4.76 P = 0.02), a higher total lungs involvement score (8.73 ± 5.28 P < 0.001), and an increased number of affected lobes (4.42 ± 1.2 P < 0.001).CONCLUSIONThe statistical analysis shows fatty liver is much more prevalent among COVID-19 against non-COVID-19 patients, and they develop more severe disease and have to be hospitalized for more extended periods.
- 6 August 2021
- Published by Springer Nature in Research Square
Open AccessRole of Fatty Liver in Coronavirus Disease 2019 Patients' Disease Severity and Hospitalization Length: a Case-control Study
BACKGROUND AND PURPOSEFatty liver is one of the most common pre-existing illnesses; it can cause liver injury, leading to further complications for coronavirus disease 2019 patients. Our goal is to determine if pre-existing fatty liver is more prevalent in hospitalized COVID-19 patients compared to patients administrated before the SARS-CoV-2 pandemic and determine the severity of the disease among fatty liver patients.EXPERIMENTAL APPROACHThis retro-perspective study involves a case and a control group consisting of 1162 patients; the case group contains hospitalized COVID-19 patients with positive PCR tests and available CT-scan; the control group contains patients with available imaging data previous to the COVID-19 pandemic. Patients’ data such as liver Hounsfield unit, days of hospitalization, number of affected lobes, and total lungs involvement score were extracted and compared between the patients.RESULTSThe findings indicate that 37.9% of hospitalized COVID-19 patients have a pre-existing fatty liver, which is significantly higher (P < 0.001) than the prevalence of pre-existing fatty liver in control group patients (9.02%). In comparison to hospitalized non-fatty liver COVID-19 patients, data from hospitalized COVID-19 patients with fatty liver indicates longer hospitalization length (6.81 ± 4.76 P = 0.02), a higher total lungs involvement score (8.73 ± 5.28 P < 0.001), and an increased number of affected lobes (4.42 ± 1.2 P < 0.001).CONCLUSIONThe statistical analysis shows fatty liver is much more prevalent among COVID-19 against non-COVID-19 patients, and they develop more severe disease and have to be hospitalized for more extended periods.
- Open Access
- 1 October 2019
- Published by Taylor & Francis in Hepatic Medicine: Evidence and Research
- Vol. ume 11, 153-158
Analysis Of Risk Factors For Nonalcoholic Fatty-Liver Disease In Hepatitis B Virus Infection: A Case–Control Study
Background: Nonalcoholic fatty-liver disease (NAFLD) is the most common cause of chronic liver disease worldwide. Although NAFLD has been studied extensively, potential risk factors for NAFLD among chronic hepatitis B (CHB) patients and their comparison with healthy individuals have remained understudied in Iran. As such, we examined the association between HBV infection and the development of NAFLD in two groups. Methods: A case–control study was done on 376 CHB patients and 447 healthy subjects randomly selected from Birjand, South Khorasan province, Iran. We used logistic regression to estimate adjusted ORs with 95% CIs for incidence of NAFLD. Potential risk factors for NAFLD were evaluated while adjusting for age, sex, marital status, and educational level. Also, χ2 was used to compare demographic characteristics between the two groups. Results: A total of 373 CHB patients (mean age 40.1±12.9 years) versus 447 individuals in the control group (mean age 39.8±13.9 years) were included in this study (p=0.337). Liver characteristics were found to be significantly different in CHB and healthy groups (pConclusion: The results suggested that HBsAg seropositivity was associated with lower risk of developing NAFLD. This study also revealed that mild cases of fatty liver in carriers of hepatitis B are more common than in healthy subjects. However, moderate and severe cases of this condition are more common in healthy people than in hepatitis B carriers.
- 1 October 2019
- Published by Taylor & Francis in Hepatic Medicine: Evidence and Research
- Vol. ume 11, 153-158
Open AccessAnalysis Of Risk Factors For Nonalcoholic Fatty-Liver Disease In Hepatitis B Virus Infection: A Case–Control Study
Background: Nonalcoholic fatty-liver disease (NAFLD) is the most common cause of chronic liver disease worldwide. Although NAFLD has been studied extensively, potential risk factors for NAFLD among chronic hepatitis B (CHB) patients and their comparison with healthy individuals have remained understudied in Iran. As such, we examined the association between HBV infection and the development of NAFLD in two groups. Methods: A case–control study was done on 376 CHB patients and 447 healthy subjects randomly selected from Birjand, South Khorasan province, Iran. We used logistic regression to estimate adjusted ORs with 95% CIs for incidence of NAFLD. Potential risk factors for NAFLD were evaluated while adjusting for age, sex, marital status, and educational level. Also, χ2 was used to compare demographic characteristics between the two groups. Results: A total of 373 CHB patients (mean age 40.1±12.9 years) versus 447 individuals in the control group (mean age 39.8±13.9 years) were included in this study (p=0.337). Liver characteristics were found to be significantly different in CHB and healthy groups (pConclusion: The results suggested that HBsAg seropositivity was associated with lower risk of developing NAFLD. This study also revealed that mild cases of fatty liver in carriers of hepatitis B are more common than in healthy subjects. However, moderate and severe cases of this condition are more common in healthy people than in hepatitis B carriers.